Clinical Trials Logo

Clinical Trial Summary

The project focuses on non-compliance in patients with systemic lupus erythematosus taking Plaquenil. More than half of patients with chronic illness are not or only poorly compliant with their treatment and lupus is one of them. The investigators want to use an already validated existing questionnaire in English, the Morisky Medication Adherence Scale 8 (MMAS 8). These results will make it possible, after a multivariate study with reference to the gold standard which is hydroxychloroquinemia, to see which exact questions in the questionnaire can be used in general medicine practices in order to detect less or non-compliant patients as early as possible.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06161363
Study type Observational
Source University Hospital, Toulouse
Contact Laurent Sailler, MD
Phone 0561779654
Email sailler.l@chu-toulouse.fr
Status Recruiting
Phase
Start date November 29, 2023
Completion date May 28, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03543839 - Trial of Belimumab in Early Lupus Phase 4
Terminated NCT02080195 - Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE) Phase 1/Phase 2
Completed NCT03098823 - A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE Phase 4
Recruiting NCT03562065 - Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord Phase 1/Phase 2
Recruiting NCT05545839 - Transition to Adulthood Through Coaching and Empowerment in Rheumatology N/A
Completed NCT05098600 - The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic
Completed NCT04128579 - Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis Phase 1
Completed NCT03421184 - Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus N/A
Not yet recruiting NCT02891213 - Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus. N/A
Completed NCT01686555 - A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE) Phase 1
Active, not recruiting NCT04018222 - Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
Completed NCT02747277 - Analysis of B Cells From Autoimmune Individuals
Not yet recruiting NCT06426316 - The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology. N/A
Recruiting NCT04213690 - A Pilot Study to Explore the Role of Gut Flora in Lupus
Recruiting NCT03913754 - Psycho-social Consequences of Systemic Lupus Erythematosus
Recruiting NCT06072287 - The Living With a Long-Term Condition Study
Completed NCT02455089 - Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus N/A
Completed NCT04089930 - Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) Patients
Completed NCT05945784 - Exploring Accessible Beauty for Individuals With Upper Extremity Deficits
Completed NCT03253666 - Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)